Economic analysis of fluconazole versus amphotericin B for the treatment of candidemia in non-neutropenic patients.
Dranitsaris G, Phillips P, Rotstein C, Puodziunas A, Shafran S, Garber G, Smaill F, Salit I, Miller M, Williams K, Conly J, Singer J, Ioannou S.
Dranitsaris G, et al. Among authors: singer j.
Pharmacoeconomics. 1998 May;13(5 Pt 1):509-18. doi: 10.2165/00019053-199813050-00004.
Pharmacoeconomics. 1998.
PMID: 10180750
Clinical Trial.